🎗️ Oncology Papers

Scholarly works matching "oncology" in Crossref, sorted by the number of times other DOI-registered works cite them. Citation counts come from Crossref and are usually lower than Google Scholar figures.

575 top-cited papers indexed

Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials

Joe Y Chang, Suresh Senan et al. (2015)

The Lancet Oncology

1.2K citesjournal articlePDF

First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial

Luis Paz-Ares, Tudor-Eliade Ciuleanu et al. (2021)

The Lancet Oncology

1.3K citesjournal articlePDF

A Randomized Trial Comparing Postoperative Adjuvant Chemotherapy with Cisplatin and 5-Fluorouracil Versus Preoperative Chemotherapy for Localized Advanced Squamous Cell Carcinoma of the Thoracic Esophagus (JCOG9907)

Nobutoshi Ando, Hoichi Kato et al. (2011)

Annals of Surgical Oncology

1.2K citesjournal articlePDF

KRAS Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab

Astrid Lièvre, Jean-Baptiste Bachet et al. (2008)

Journal of Clinical Oncology

1.2K citesjournal articlePDF

Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy

J.M. Pitt, A. Marabelle et al. (2016)

Annals of Oncology

1.2K citesjournal articlePDF

Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen

Eric Van Cutsem, Josep Tabernero et al. (2012)

Journal of Clinical Oncology

1.2K citesjournal articlePDF

Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016

Global Burden of Disease Cancer Collaboration, Christina Fitzmaurice et al. (2018)

JAMA Oncology

1.2K citesjournal articlePDF

Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical trial

(2009)

The Lancet Oncology

1.2K citesjournal articlePDF

Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial

Naiyer A Rizvi, Julien Mazières et al. (2015)

The Lancet Oncology

1.2K citesjournal articlePDF

Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated

Sandra Demaria, Bruce Ng et al. (2004)

International Journal of Radiation Oncology*Biology*Physics

1.2K citesjournal articlePDF

Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

G. Argilés, J. Tabernero et al. (2020)

Annals of Oncology

1.3K citesjournal articlePDF

Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations

Judith A. Seidel, Atsushi Otsuka et al. (2018)

Frontiers in Oncology

1.2K citesjournal articlePDF

American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003

David G. Pfister, David H. Johnson et al. (2004)

Journal of Clinical Oncology

1.2K citesjournal articlePDF

Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial

Piet Ost, Dries Reynders et al. (2018)

Journal of Clinical Oncology

1.2K citesjournal articlePDF

Measuring Quality of Life in Routine Oncology Practice Improves Communication and Patient Well-Being: A Randomized Controlled Trial

Galina Velikova, Laura Booth et al. (2004)

Journal of Clinical Oncology

1.2K citesjournal articlePDF